OPHTHALMOLOGY
Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study
Purpose To compare the efficacy and safety of the European labels of ranibizumab 0.5 mg vs dexamethasone 0.7 mg in patients with macular edema secondary to central retinal vein occlusion (CRVO). Design…
Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours
Purpose To compare the diurnal and nocturnal effects of latanoprostene bunod 0.024% solution with timolol maleate 0.5% solution on intraocular pressure (IOP) and ocular perfusion pressure. Design Prospective, open-label randomized…
Penetrating Keratoplasty for Keratoconus With and Without Resolved Corneal Hydrops: Long-term Results
Purpose To evaluate the long-term risk of endothelial rejection, graft survival, and associated factors following penetrating keratoplasty (PK) for keratoconus, with and without prior resolved corneal hydrops. Design Retrospective cohort…
Has the Time Come for All to Routinely Use Intracameral Antibiotic Prophylaxis at the Time of Cataract Surgery?
I read with interest the article by Olson ; however, I believe that some discussion of the paper is needed. It was shown in several studies that the similar endophthalmitis…
Central Corneal Thickness and its Associations With Ocular and Systemic Factors in an Urban West African Population
Purpose To assess the associations of central corneal thickness (CCT) with ocular and systemic factors in a West African population. Design Population-based cross-sectional study. Methods Participants aged ≥40 years in…
Stevens-Johnson Syndrome and Corneal Ectasia: Management and a Case for Association
Purpose To report the occurrence of corneal ectasia (ECT) in patients with history of Stevens-Johnson syndrome (SJS), and to make the case for an association between these 2 diagnoses. We…
Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study
We would like to address several challenges arising from the interesting study by Hoerauf and associates, which can be specifically summarized as follows: We do not agree with the assertion…
